1[1]Callahan LF. The burden of rheumatoid arthrits: facts and figures [J]. J Rheumtol, 1998, 25 (supp153): 8-12.
2[2]Ralf wassmuth, Ulf wagner. Prognostic use of human leukocyte antigen genotyping for rheumatoid arthritis susceptibility, disease couse, and clinical stratification[J]. Rheumatic Disease Clinics Of North America, Feb 2002, 28 (1): 13-37.
3[3]Frank C, Arnett, Steven M, Edworthy, Daniela, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis and rheumatism, Mar1988, 31 (3): 315-325.
5[5]Henk Visser, Saskia Le Cessie, Koen Vos, Ferdinand C, et al. How to diagnose rheumatoid arthritis early [J]. Arthritis and rheumatism, Feb 2002, 46 (2): 357-365.
6[6]Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide [J]. Amm Rheum Dis, 2002, 61: 290-297.
7[8]Aho K, Palosuo T, Lukka M, Kurki P, et al. Antifilaggrin antibodies in recent-onset arthritis [J]. Scandinavian journal of rheumatology, 1999, 28 (2): 113-116.
8[9]Vincent C, De Keyser F, Masson Bessiere C, et al. Anti-perinclear factor compared with the so called antikeratin antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides[J]. Annals of the rheumatic diseases, 1999, 58 (1):42-48.
9[10]Vittecoq O, Jouen Beades F, Krzanowska K, et al. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community caese of rheumatoid arthritis. A preliminary study[J]. Join Bone Spine, 2001, 68 (2): 144-153.
10[11]Forslin K, Vincent C, Serre G, et al. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progreesion[J]. Scandinavian journal of rheumatology, 2001, 30 (4): 221-224.
